全文获取类型
收费全文 | 104304篇 |
免费 | 11581篇 |
国内免费 | 7034篇 |
专业分类
耳鼻咽喉 | 831篇 |
儿科学 | 1799篇 |
妇产科学 | 1019篇 |
基础医学 | 8800篇 |
口腔科学 | 1950篇 |
临床医学 | 14681篇 |
内科学 | 11701篇 |
皮肤病学 | 1060篇 |
神经病学 | 3317篇 |
特种医学 | 3696篇 |
外国民族医学 | 36篇 |
外科学 | 7049篇 |
综合类 | 24224篇 |
现状与发展 | 35篇 |
一般理论 | 1篇 |
预防医学 | 10651篇 |
眼科学 | 2848篇 |
药学 | 13055篇 |
194篇 | |
中国医学 | 9407篇 |
肿瘤学 | 6565篇 |
出版年
2024年 | 617篇 |
2023年 | 1792篇 |
2022年 | 4541篇 |
2021年 | 5636篇 |
2020年 | 4816篇 |
2019年 | 3304篇 |
2018年 | 3355篇 |
2017年 | 3948篇 |
2016年 | 3155篇 |
2015年 | 5231篇 |
2014年 | 6440篇 |
2013年 | 7002篇 |
2012年 | 9848篇 |
2011年 | 10507篇 |
2010年 | 7821篇 |
2009年 | 6417篇 |
2008年 | 6919篇 |
2007年 | 6531篇 |
2006年 | 5960篇 |
2005年 | 4622篇 |
2004年 | 3142篇 |
2003年 | 2859篇 |
2002年 | 2164篇 |
2001年 | 1765篇 |
2000年 | 1324篇 |
1999年 | 871篇 |
1998年 | 441篇 |
1997年 | 424篇 |
1996年 | 308篇 |
1995年 | 302篇 |
1994年 | 224篇 |
1993年 | 111篇 |
1992年 | 90篇 |
1991年 | 79篇 |
1990年 | 80篇 |
1989年 | 49篇 |
1988年 | 57篇 |
1987年 | 45篇 |
1986年 | 22篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 9篇 |
1980年 | 6篇 |
1979年 | 10篇 |
1977年 | 5篇 |
1970年 | 7篇 |
1967年 | 3篇 |
1966年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献
22.
24.
25.
26.
目的以冰粒子为致孔剂,用粒子滤出—冷冻干燥复合工艺制备PHB多孔支架。方法本实验以氯仿为溶剂,将PHB溶液浇入预先排列好的冰微粒空隙中,采用真空渗流方法制备冰微料-PHB复合体,液氮冷却成型后,用粒子滤出—冷冻干燥复合工艺制备多孔支架。通过扫描电镜(SEM)观测,研究该制备工艺对支架形貌的影响。结果制备的块状三维多孔支架孔径可调、孔隙结构良好、孔隙连通度高。结论本文工艺所制备的多孔支架无致孔剂残留,孔隙率高,孔隙连通度高,制备过程不会损害材料的生物相容性,可安全地用于组织工程可降解聚合物多孔支架的制备。 相似文献
27.
28.
分别用水和乙醇作为溶剂加热提取枳椇子中的总黄酮,用比色法测定黄酮的含量,分别以提取时间、加热温度、料液比、提取次数等因素进行正交试验.对两种提取方法进行比较,确定各因素对提取效果的影响并对其解酒作用进行研究.水提取法的最优条件是:100 ℃,料液比1 g:8 mL,加热0.5 h,回流提取3次;醇提取法的最佳条件:80 ℃,料液比1 g:6 mL,加热1.5 h,以体积分数50%的乙醇回流提取3次.实验结果显示,醇提取法比水提取法效果更好,枳椇子提取液具有一定的解酒作用. 相似文献
29.
Weiping Ren Bin Wu Xin Peng Jing Hua Hsiao-Nan Hao Paul H Wooley 《Journal of orthopaedic research》2006,24(8):1575-1586
Signaling of RANK (receptor activator of nuclear factor kappa B) through its ligand RANKL appears critical in osteolysis associated with aseptic loosening (AL). The purpose of this study was to investigate the role of RANK in a murine osteolysis model developed in RANK knockout (RANK(-/-)) mice. Ultra high molecular weight polyethylene (UHMWPE) debris was introduced into established air pouches on RANK(-/-) mice, followed by implantation of calvaria bone from syngeneic littermates. Wild type C57BL/6 (RANK(+/+)) mice injected with either UHMWPE or saline alone were included in this study. Pouch tissues were collected 14 days after UHMWPE inoculation for molecular and histology analysis. Results showed that UHMWPE stimulation induced strong pouch tissue inflammation in RANK(-/-) mice, as manifested by inflammatory cellular infiltration, pouch tissue proliferation, and increased gene expression of IL-1beta, TNFalpha, and RANKL. However, the UHMWPE-induced inflammation in RANK(-/-) mice was not associated with the osteoclastic bone resorption observed in RANK(+/+) mice. In RANK(+/+) mice subjected to UHMWPE stimulation, a large number of TRAP(+) cells were found on the implanted bone surface, where active osteoclastic bone resorption was observed. No TRAP(+) cells were found in UHMWPE-containing pouch tissues of RANK(-/-) mice. Consistent with the lack of osteoclastic activity shown by TRAP staining, no significant UHMWPE particle-induced bone resorption was found in RANK(-/-) mice. A well preserved bone collagen content (Van Gieson staining) and normal plateau surface contour [microcomputed tomography (microCT)] of implanted bone was observed in RANK(-/-) mice subjected to UHMWPE stimulation. In conclusion, this study provides the evidence that UHMWPE particles induce strong inflammatory responses, but not associated with osteoclastic bone resorption in RANK(-/-) mice. This indicates that RANK signaling is essential for UHMWPE particle-induced osteoclastic bone resorption, but does not participate in UHMWPE particle-induced inflammatory response. 相似文献
30.